Literature DB >> 14963313

Policy rebuttal. HIV vaccine trial justified.

John G McNeil1, Margaret I Johnston, Deborah L Birx, Edmund C Tramont.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Substances：

Year:  2004        PMID： 14963313     DOI： 10.1126/science.1096161

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

Review 1.  Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative.

Authors:  Timothy J Tucker; Gatsha Mazithulela
Journal:  BMJ       Date:  2004-08-21

Review 2.  Current advances in HIV vaccines.

Authors:  M Patricia D'Souza; Mary Allen; Rebecca Sheets; Margaret I Johnston
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

3.  Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.

Authors:  Ranajit Pal; David Venzon; Sampa Santra; Vaniambadi S Kalyanaraman; David C Montefiori; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Janos Nacsa; Yvette Edghill-Smith; Marcin Moniuszko; Zdenek Hel; Igor M Belyakov; Jay A Berzofsky; Robyn Washington Parks; Phillip D Markham; Norman L Letvin; Jim Tartaglia; Genoveffa Franchini
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.

Authors:  Peter B Gilbert; James O Berger; Donald Stablein; Stephen Becker; Max Essex; Scott M Hammer; Jerome H Kim; Victor G Degruttola
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

5.  HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Authors:  Mangala Rao; Kristina K Peachman; Jiae Kim; Guofen Gao; Carl R Alving; Nelson L Michael; Venigalla B Rao
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

6.  Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

Authors:  David I Watkins; Dennis R Burton; Esper G Kallas; John P Moore; Wayne C Koff
Journal:  Nat Med       Date:  2008-06       Impact factor: 53.440

7.  Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as prevention.

Authors:  Theodore C Bailey; Jeremy Sugarman
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581

8.  Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.

Authors:  Poonam Pegu; Monica Vaccari; Shari Gordon; Brandon F Keele; Melvin Doster; Yongjun Guan; Guido Ferrari; Ranajit Pal; Maria Grazia Ferrari; Stephen Whitney; Lauren Hudacik; Erik Billings; Mangala Rao; David Montefiori; Georgia Tomaras; S Munir Alam; Claudio Fenizia; Jeffrey D Lifson; Donald Stablein; Jim Tartaglia; Nelson Michael; Jerome Kim; David Venzon; Genoveffa Franchini
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

Review 9.  Current situation in the development of a preventive HIV vaccine.

Authors:  José Alcamí; Joan Joseph Munné; María Angeles Muñoz-Fernández; Mariano Esteban
Journal:  Enferm Infecc Microbiol Clin       Date:  2005-07       Impact factor: 1.731
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.